DMEPOS Supplier Accreditation FAQ — Your Questions Answered

Last updated: April 2026

Answers to the most common questions about CMS DMEPOS supplier accreditation requirements, the 2026 rule changes, accreditor selection, process, costs, and risk — from IHS, the only URAC-certified accreditation consulting firm in the United States.

DMEPOS Accreditation Consulting Overview | ACHC vs. BOC vs. TCT Comparison | Cost Guide

What Is DMEPOS Accreditation?

What does DMEPOS stand for and what types of suppliers need accreditation?

DMEPOS stands for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Any organization billing Medicare for covered DMEPOS items — hospital beds, wheelchairs, respiratory equipment, diabetic testing supplies, orthotics, continuous glucose monitors (CGMs), enteral nutrition, and more — must hold active accreditation from a CMS-approved accrediting organization as a mandatory condition of Medicare enrollment.

The rule is broad: if your organization receives Medicare reimbursement for any item in the DMEPOS category, you need accreditation. This includes traditional HME/DME suppliers, pharmacies billing DMEPOS codes, O&P clinics, physical therapists providing OTS orthotics, dental sleep medicine practices, and retailers distributing DMEPOS products across state lines.

Is DMEPOS accreditation required for all suppliers or only those billing Medicare?

Accreditation is required only for suppliers billing Medicare for DMEPOS items — it is a condition of Medicare enrollment specifically. 100% of the approximately 8,005 active traditional Medicare DMEPOS supplier locations nationwide hold CMS-recognized accreditation because Medicare is typically the largest payer. (Source: OAMES, January 2024) Private pay and Medicaid-only suppliers are not federally required to be accredited, though individual state Medicaid programs may impose their own accreditation requirements.

Which accreditation organizations are currently CMS-approved for DMEPOS?

Nine organizations hold CMS approval for DMEPOS accreditation as of early 2026:

ACHC (Accreditation Commission for Health Care) — most widely used, broadest product category coverage, standards updated August 29, 2025
The Compliance Team (TCT) — real-time web-based portal for ongoing documentation, strong for 2026 annual survey readiness
BOC (Board of Certification/Accreditation) — reinstated under TRO January 9, 2026; CA/FL/NY/TX regional restrictions remain; federal litigation pending
ABC (American Board for Certification in O&P/Pedorthics) — transparent published fee schedule, strong for O&P clinics
CHAP (Community Health Accreditation Program) — strong for home-based care suppliers
TJC (The Joint Commission)
HQAA (Healthcare Quality Association on Accreditation)
NABP (National Association of Boards of Pharmacy) — efficient path for pharmacy-based DMEPOS billing
DNV Healthcare

IHS has no financial relationship with any accrediting organization and selects the right AO for each client based solely on their needs. See our ACHC vs. BOC vs. TCT Comparison for the detailed side-by-side analysis.

What are the CMS DMEPOS Supplier Quality Standards?

The CMS DMEPOS Supplier Quality Standards are the baseline federal requirements every Medicare-enrolled DMEPOS supplier must meet. They cover: supplier code of conduct, complaint handling processes, patient privacy and HIPAA, equipment cleaning and maintenance, delivery and setup requirements, employee training and competency verification, quality improvement programs, and emergency preparedness. Accrediting organizations verify compliance with these standards (plus their own supplemental requirements) through unannounced on-site surveys.

What is "deemed status" in the DMEPOS accreditation context?

Deemed status means CMS has determined that holding accreditation from a specific AO satisfies CMS's own verification requirements. Instead of CMS conducting its own separate inspection, the AO's accreditation decision is "deemed" sufficient. Deemed status is why accreditation from a CMS-approved AO is a legal condition of Medicare enrollment — it is CMS's delegated quality oversight mechanism for the DMEPOS supplier industry.

Who Needs DMEPOS Accreditation?

Do pharmacies need separate DMEPOS accreditation to bill for diabetic supplies or orthotics?

Yes — pharmacies billing Medicare for DMEPOS-covered products (diabetic testing supplies, enteral nutrition, off-the-shelf orthotics) must hold DMEPOS supplier accreditation. Standard pharmacy accreditation (URAC, ACHC pharmacy, NABP PCAB) does not cover DMEPOS billing by itself. NABP accreditation covers both pharmacy and certain DMEPOS billing categories in a single credential for qualifying pharmacies — making it an efficient path for pharmacies with limited DMEPOS billing volume. ACHC's pharmacy division is another common route.

Are home infusion therapy suppliers subject to DMEPOS accreditation rules?

Home infusion therapy has its own Medicare benefit category with separate billing and accreditation requirements under Section 5012 of the 21st Century Cures Act. However, suppliers billing for infusion pumps or certain enteral nutrition products that fall under DMEPOS codes must also hold DMEPOS supplier accreditation for those specific categories. IHS assesses both HIT and DMEPOS requirements in a combined gap analysis for suppliers with overlapping service lines.

What is the DMEPOS Competitive Bidding Program and does it add accreditation requirements?

The DMEPOS Competitive Bidding Program (CBP) is CMS's mechanism for setting Medicare reimbursement rates for select DMEPOS categories through a competitive bidding process. Only actively accredited suppliers may submit bids in CBP. The 2028 CBP round covers Class II CGMs/Insulin Pumps, Urological/Ostomy Supplies, and OTS Braces. The bid window opens Late Summer/Early Fall 2026. Accreditation is not an add-on for CBP — it is a prerequisite. A supplier without active accreditation at bid submission is disqualified outright. [citation needed for CBP projections]

How Does the DMEPOS Accreditation Process Work?

What are the steps to get DMEPOS supplier accreditation?

Six phases from non-compliant to Medicare-enrolled:

Weeks 1–3: Gap Assessment — review operations and documentation against CMS Quality Standards and AO standards manual to identify vulnerabilities
Weeks 4–8: Policy and Procedure Development — customize required P&P for your specific product categories, including TB control plans, equipment cleaning protocols, complaint procedures, and corporate compliance frameworks
Weeks 9–12: Implementation and Training — train staff on HIPAA, FWA, OSHA, patient equipment instruction; generate compliant training documentation logs
Weeks 13–14: Mock Survey — unannounced simulated survey with staff interviews, facility inspection, and tracer exercises
Weeks 15–20+: Application and Live Survey — submit application and non-refundable deposit; AO dispatches unannounced surveyor
Weeks 20–30+: Plan of Correction and PECOS Enrollment — resolve any cited deficiencies; submit CMS-855S through PECOS for Medicare enrollment

What changed with the 2026 annual survey requirement and what does it mean operationally?

Effective January 1, 2026, CMS requires DMEPOS suppliers to be resurveyed at least once every 12 months. Previously, surveys occurred every 36 months. The operational shift is fundamental: ad hoc accreditation preparation every three years is no longer viable. Continuous readiness is now the operational standard — meaning ongoing documentation hygiene, regular internal audits, and continuous staff training. Organizations with more than $2 million in annual Medicare billing need 0.5 to 1.0 dedicated FTE focused on QAPI. Failing the annual survey triggers an 18-month Medicare billing suspension — the stakes of under-investing in ongoing compliance have tripled. (Source: VGM regulatory update, January 2026)

What is a Corrective Action Plan (CAP) and what are the submission timelines?

A CAP (also called a Plan of Correction) is the formal written response submitted to the AO when a surveyor cites deficiencies during the on-site survey. The CAP must document: what specific corrective action was taken for each cited deficiency, who was responsible, and the completion date. AO-specific submission deadlines typically run 10 to 30 days from receipt of the deficiency report. ACHC provides a structured template; TCT manages CAP submissions through its real-time web portal. Failure to submit a timely, substantive CAP can result in accreditation denial and require a full re-survey.

What happened to the 90-day temporary billing grace period for new DMEPOS locations?

Eliminated. Effective January 1, 2026, every new DMEPOS physical location must be fully surveyed and accredited before billing a single Medicare claim. The 90-day temporary billing authorization that previously allowed new locations to begin billing while awaiting accreditation no longer exists. For multi-location operators or organizations planning expansion, this change requires building complete accreditation preparation into the pre-opening timeline — adding 4 to 8 months to new location launch planning. (Source: CMS DMEPOS Accreditation Guidance)

What is the CMS enrollment timeline after receiving DMEPOS accreditation?

After accreditation award, the supplier submits Form CMS-855S through PECOS (Provider Enrollment, Chain, and Ownership System). CMS's federal mandate is 50 calendar days for online PECOS processing (95th percentile) or 65 calendar days for paper CMS-855S submissions. In practice, Novitas Solutions (MAC for the eastern US) frequently runs 3 to 6 months on complex DMEPOS applications. IHS monitors PECOS application status and escalates when processing exceeds standard timelines. Total time from engagement start to first Medicare claim: typically 6 to 14 months. [citation needed for Novitas backlog data]

How Much Does DMEPOS Accreditation Cost?

How much does DMEPOS accreditation cost with ACHC vs. other accrediting bodies?

Fee structures vary by AO. ABC publishes a transparent 2026 schedule: first-time primary location $1,855 (includes application and on-site survey), affiliate locations $965 each (max 4), annual maintenance $630 primary / $315 affiliate, renewal $1,225. ACHC and TCT use custom quoting; base survey fees typically run $2,000–$7,000+ with annual renewal confirmation fees of $1,000–$5,000. The $750 CMS enrollment application fee applies separately for all initial, revalidation, or new location applications. (Source: CMS CY 2026 fee schedule) Full consulting engagement: $4,500–$18,000+ per location. See our DMEPOS Accreditation Cost Guide for full fee details.

What are the ongoing costs of maintaining DMEPOS accreditation under the new annual survey rule?

Under the 2026 annual survey mandate, ongoing compliance requires: annual AO survey/renewal fee ($1,000–$5,000+), annual retainer consulting for continuous readiness ($1,000–$5,000/year), and internal FTE investment (0.5–1.0 FTE compliance officer for organizations over $2M annual Medicare billing). The pre-2026 cost model was roughly one project every three years. The annual model represents a permanent increase in compliance operating costs — offset by the elimination of catastrophic billing suspension risk from a failed triennial survey.

What are the costs of non-compliance or losing DMEPOS accreditation?

Loss of accreditation triggers: (1) immediate Medicare billing suspension for a typical 18 months, (2) civil monetary penalties exceeding $25,000 for billing while unaccredited, and (3) full re-accreditation and PECOS re-enrollment costs before billing can resume. For a supplier with $3 million in annual Medicare revenue, an 18-month suspension represents $4.5 million in lost billings — against which a $15,000 annual retainer engagement is straightforward risk management. The costs are asymmetric: compliance is expensive; non-compliance is catastrophic. (Sources: NikoHealth 2026; CMS)

What Can Go Wrong? Survey Deficiencies and Risks

What are the most common DMEPOS survey deficiencies?

Documentation errors are the primary cause of failure in 60% of failed DMEPOS surveys. Top 10 deficiencies from 2025–2026 surveys:

Equipment Cleaning and Storage (ACHC DRX7-12D) — cited in 30% of ACHC surveys for the fifth consecutive year; physical separation of clean and dirty equipment, transport infection control, warehouse sanitation (Source: ACHC 2025 [citation needed])
Safety Program Documentation — outdated oxygen storage, PPE, and fire safety policies (Source: CHAP 2025/2026)
TB Control Plans — missing personnel TB screening records per state and CDC guidelines (Source: CHAP 2025/2026)
Leadership Policy Review (TCT ADM 1.0) — no documented annual P&P review by organizational leadership (Source: TCT 2025/2026)
Ongoing HR Training (TCT HR 1.0) — missing annual FWA, HIPAA, and OSHA training logs (Source: TCT 2025/2026)
Patient Equipment Training — unsigned patient and caregiver equipment instruction forms (Source: CHAP 2025/2026)
Respiratory Setup Guidelines — misalignment with current AARC guidelines (Source: CHAP 2025/2026)
Patient File Credentialing — missing physician signatures, date stamps, or F2F encounter notes; 83 DMEPOS items now on CMS F2F/WOPD required prior authorization list as of April 13, 2026 (Source: CMS)
Complaint Log Management — no distinct accessible complaint log with documented resolution (Source: CMS)
Sanitary Environment — facility cleanliness failures in rehab modification areas or CPAP fitting rooms (Source: ACHC)

What happens to my Medicare billing if I lose DMEPOS accreditation?

Loss of accreditation triggers immediate Medicare billing suspension. The typical suspension duration is 18 months. During this period, the organization cannot submit or receive Medicare reimbursement for any covered DMEPOS item. Civil monetary penalties exceeding $25,000 apply to any Medicare billing attempted while unaccredited. Recovery requires full re-accreditation plus PECOS re-enrollment — adding months to the suspension period. A single 18-month suspension effectively eliminates most DMEPOS suppliers that fail to maintain continuous accreditation. (Source: NikoHealth 2026)

What is the BOC/CMS lawsuit situation and how does it affect my accreditation choice?

The BOC regulatory timeline: May 2025 — CMS restricted BOC in CA, FL, NY, TX. December 2, 2025 — CMS withdrew BOC approval nationwide. January 9, 2026 — Federal court granted TRO in Board of Certification/Accreditation International, Inc. v. Robert F. Kennedy, Jr. et al, reinstating BOC nationwide; CA/FL/NY/TX restrictions remain. The underlying litigation continues; the TRO may be modified pending final ruling. IHS recommends: (1) suppliers in CA/FL/NY/TX must transition to another AO; (2) suppliers elsewhere with BOC accreditation are valid under the TRO but should maintain a contingency transition plan; (3) new accreditations in those four states should not be started with BOC regardless of TRO status. (Sources: HME Business; CHAP; BOC)

How does the 36-month ownership rule affect DMEPOS M&A transactions in 2026?

The 36-month rule, expanded to DMEPOS effective January 1, 2026, terminates Medicare billing rights whenever a supplier undergoes a change in majority ownership (greater than 50%) within 36 months of enrollment or the last ownership change. For M&A buyers, this means: (1) verify whether the target triggered the 36-month window by its own enrollment or prior ownership change; (2) if a 36-month window is active, new enrollment is required — but the February 27, 2026 enrollment moratorium for DMEPOS medical supply companies (6-month duration) may prevent enrollment; (3) deal structures must account for billing interruption as a material risk factor. IHS provides M&A accreditation due diligence engagements specifically for the 36-month rule. (Sources: Hall Render; Benesch Law)

How Does DMEPOS Accreditation Compare to Alternatives?

ACHC vs. BOC vs. The Compliance Team — which DMEPOS accreditor should I choose?

The right choice depends on your product categories, state(s) of operation, and risk tolerance. ACHC: broadest product category coverage, most widely used in the market, 2025/2026 standards updated August 29, 2025. TCT: real-time web portal simplifies documentation for annual survey readiness; strong for ongoing compliance. BOC: valid under TRO but carries litigation risk; avoid in CA, FL, NY, TX. IHS provides independent accreditor selection guidance based solely on your situation. See our full ACHC vs. BOC vs. TCT Comparison page for the detailed side-by-side analysis.

How does DMEPOS accreditation differ from home health agency accreditation?

DMEPOS accreditation covers equipment and supply providers — organizations delivering products to patients. Home health agency (HHA) accreditation covers clinical care — organizations sending skilled clinicians into patients' homes. The standards frameworks, survey focus, and compliance requirements are fundamentally different, though several AOs (ACHC, CHAP, TJC) offer both. Some organizations need both — respiratory suppliers expanding into clinical services, or home infusion companies adding DMEPOS billing categories. IHS serves both and can manage dual accreditation in a single engagement. See our Home Health & Hospice Accreditation Consulting page.

Is DMEPOS accreditation recognized by Medicaid as well as Medicare?

DMEPOS accreditation is a federal Medicare requirement. Individual state Medicaid programs set their own billing requirements — some states accept federal DMEPOS accreditation as sufficient, others impose separate state licensure. Florida, Texas, California, and Illinois impose state-level requirements beyond federal accreditation regardless of Medicare status (see state-specific requirements on our service page). Medicaid managed care contracts may also impose accreditation requirements. IHS maps both federal and state Medicaid requirements in the same engagement.

Still Have Questions? Schedule a Consultation.

IHS provides independent, accreditor-neutral DMEPOS accreditation consulting. No financial relationship with any AO. No generic templates. Every engagement is built around your product mix, state exposure, and timeline.

Contact IHS: |

Adjacent services: Home Health & Hospice Accreditation